SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
MILLENNIUM PARTNERS, L.P.

(Last) (First) (Middle)
C/O MILLENNIUM MANAGEMENT LLC
666 FIFTH AVENUE, 8TH FLOOR

(Street)
NEW YORK NY 10103

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LIBERATOR MEDICAL HOLDINGS, INC. [ LBMH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/24/2013
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 4,123 (1) D (1) (3) (4) (5) (7)
Common Stock 12/24/2013 S 100,000 D $4.358 7,724,079 (2) D (2) (6) (7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
MILLENNIUM PARTNERS, L.P.

(Last) (First) (Middle)
C/O MILLENNIUM MANAGEMENT LLC
666 FIFTH AVENUE, 8TH FLOOR

(Street)
NEW YORK NY 10103

(City) (State) (Zip)
1. Name and Address of Reporting Person*
ICS OPPORTUNITIES, LTD.

(Last) (First) (Middle)
C/O MILLENNIUM INTL. MGMT. LP
666 FIFTH AVENUE, 8TH FLOOR

(Street)
NEW YORK NY 10103

(City) (State) (Zip)
1. Name and Address of Reporting Person*
MILLENNIUM INTERNATIONAL MANAGEMENT LP

(Last) (First) (Middle)
C/O MILLENNIUM INTL. MGMT. GP LLC
666 FIFTH AVENUE, 8TH FLOOR

(Street)
NEW YORK NY 10103

(City) (State) (Zip)
1. Name and Address of Reporting Person*
MILLENNIUM INTERNATIONAL MANAGEMENT GP LLC

(Last) (First) (Middle)
666 FIFTH AVENUE, 8TH FLOOR

(Street)
NEW YORK NY 10103

(City) (State) (Zip)
1. Name and Address of Reporting Person*
MILLENNIUM MANAGEMENT LLC

(Last) (First) (Middle)
666 FIFTH AVENUE, 8TH FLOOR

(Street)
NEW YORK NY 10103

(City) (State) (Zip)
1. Name and Address of Reporting Person*
ENGLANDER ISRAEL A

(Last) (First) (Middle)
C/O MILLENNIUM MANAGEMENT LLC
666 FIFTH AVENUE, 8TH FLOOR

(Street)
NEW YORK NY 10103

(City) (State) (Zip)
Explanation of Responses:
1. As of the close of business on December 24, 2013, ICS Opportunities, Ltd., an exempted limited company organized under the laws of the Cayman Islands ("ICS Opportunities"), beneficially owned 4,123 shares of common stock, par value $0.001 per share (the "Common Stock"), of Liberator Medical Holdings, Inc. (the "Issuer").
2. As of the close of business on December 24, 2013, Millennium Partners, L.P., a Cayman Islands exempted limited partnership ("Millennium Partners"), beneficially owned 7,724,079 shares of the Issuer's Common Stock .
3. Millennium International Management LP, a Delaware limited partnership ("Millennium International Management"), is the investment manager to ICS Opportunities, and consequently may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities.
4. Millennium International Management GP LLC, a Delaware limited liability company ("Millennium International Management GP"), is the general partner of Millennium International Management, and consequently may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities.
5. Millennium Management LLC, a Delaware limited liability company ("Millennium Management"), is the general partner of the 100% shareholder of ICS Opportunities, and consequently may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities.
6. Millennium Management is also the general partner of Millennium Partners, and may be deemed to have shared voting control and investment discretion over securities owned by Millennium Partners.
7. Israel A. Englander ("Mr. Englander"), is the managing member of Millennium International Management GP and Millennium Management, and consequently may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and Millennium Partners.
Remarks:
* MILLENNIUM PARTNERS, L.P. By: Millennium Management LLC, its General Partner
* David Nolan, Vice Chairman 12/24/2013
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.